James M. Mock, Chief Financial Officer at Moderna, Inc. (MRNA), sold 1,296 shares at $162.47 ($211K) on 2024-05-28, disclosed to the SEC on 2024-05-29.
Scheduled sale ($211k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $162.47 | 648 | $105K | 50.0% |
| 2 | $162.47 | 648 | $105K | 50.0% |
| Total | $162.47 avg | 1,296 | $211K | 100% |
| Filing → |
| MRNA | SELL | 2024-10-08 | $43K | — | Filing → |
| MRNA | SELL | 2024-08-30 | $13K | — | Filing → |
| MRNA | SELL | 2024-08-29 | $210K | — | Filing → |